What are the ESMO guidelines on the treatment of on treatment of urothelial tumors of the renal pelvis and ureters?

Updated: Aug 07, 2020
  • Author: Kyle A Richards, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

The EAU guidelines include the following key treatment recommendations [1]

  • Kidney-sparing management is the primary treatment option for low-risk tumors.
  • Kidney-sparing management should be offered to patients with high-risk distal ureteral tumors.
  • Kidney-sparing management should be offered to select patients with solitary kidney and/or impaired renal function, provided it will not compromise survival.
  • Laser endoscopic treatment can be used for upper tract urothelial carcinoma.
  • For high-risk tumors, radical nephroureterectomy with cuff of bladder and regional lymphadenectomy and postoperative bladder instillation of chemotherapy should be offered

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!